There is an urgent need for interventions that improve healing time, prevent amputations and recurrent ulceration in patients with diabetes-related foot wounds. In this randomised, open-label trial, participants were randomised […]
Wound healing with “spray-on” autologous skin grafting (ReCell) compared with standard care in patients with large diabetes-related foot wounds: an open-label randomised controlled trial.
- August 11, 2021
- 12:35 pm
Facebook
Twitter
LinkedIn
WhatsApp
donate
Recent posts
Quick Facts – CTP Reimbursement
December 1, 2023
Pressure Injury Prevention
November 1, 2023
Mandi Test
October 5, 2023
Quick Facts – Surgical Wound Management
October 2, 2023
Surgical Wound Management
October 2, 2023